冠昊生物：公司当前生产经营活动正常有序

Group 1 - The core viewpoint of the article is that Guanhao Biological has confirmed that its current production and operational activities are normal and orderly, with no undisclosed significant risk matters [2] Group 2 - The company responded to investor inquiries on its interactive platform, reinforcing its operational stability [2] - The statement indicates transparency in the company's communication with investors regarding its risk status [2]